Hyoscine N-butyl bromide (HNBB), also termed as scopolamine, is a type of anti-muscarinic agent. It is an active ingredient of Hyoscine Butylbromide, Buscopan, and hyospasmol. It is an anti-spasmodic drug used to treat conditions related to spasms of the gastrointestinal tract, like cramping. It is also used in combination with the other drugs to release painful menstruation.
This report elaborates the market size, market characteristics, and market growth of the Hyoscine-N-Butyl Bromide industry, and breaks down according to the type, application, and consumption area of Hyoscine-N-Butyl Bromide. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hyoscine-N-Butyl Bromide in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Hyoscine-N-Butyl Bromide market covered in Chapter 13:
Biotechnica Pharma Global (BPG)
Alkaloids
ALPS Pharmaceutical Ind. Co. Ltd.
Boehringer Ingelheim group
Linnea
Boehringer-Ingelheim
Alchem International
Nectar Lifesciences Ltd. (NLL)

In Chapter 6, on the basis of types, the Hyoscine-N-Butyl Bromide market from 2015 to 2025 is primarily split into:
Liquid
Powder
Granular

In Chapter 7, on the basis of applications, the Hyoscine-N-Butyl Bromide market from 2015 to 2025 covers:
Oral
Injection

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025